Progress Software Corp. (PRGS)

Progress Software Corp. (PRGS) is trading near the top of its 52-week range, at 87% of the way from the low to the high, after a six-month gain of 67.99%. The stock fell 8.48% in the first session after its September 30, 2026 report even though adjusted EPS of $1.69 beat the estimate by 9.74%. Analysts remain constructive: four of five ratings are Buy or Strong Buy, and the median 12-month target of $53.00 sits 19.6% above the price.

Progress reported adjusted EPS of $1.69 for the period ended September 30, 2026, a 9.74% beat over the estimate. The share price nonetheless fell 8.48% in the first trading session after the report. The June 30, 2026 report beat by 8.72% and was followed by a 16.62% rise, so the market's reaction to beats has been mixed. Investors appear to be weighing the guidance and the top line more heavily than the headline EPS figure. The pattern is not new. Progress has beaten the EPS estimate in all eight of its recent reports, yet the share price was lower in the first session after four of them and higher after the other four. A beat on the bottom line has therefore not reliably translated into a higher share price on the day that follows.

Profitability is solid by comparison: the net profit margin is 9.24%, the operating margin 21.98%, and return on equity 18.34%, above the sector median of 13.4%. Debt is the other pressure point, with a debt-to-equity ratio of 2.39. The gap between shrinking sales and strong margins is the central question for the stock.

At a trailing P/E of 20.41, the stock trades 41.9% below the sector median P/E of 35.1, and its price-to-sales ratio of 1.81 compares with a sector median of 7.6. CleaRank's valuation check puts the stock at a discount to peers on earnings. The discount reflects the slowing top line; a low multiple on shrinking revenue is a different proposition from a low multiple on growing sales. The stock has still roughly doubled from its 52-week low of $23.82 to $44.30, and the six-month return of 67.99% shows that most of that gain came in the past six months.

Five analysts cover the stock. Four rate it Buy or Strong Buy and one holds it, with none at Sell. DA Davidson kept its Buy rating on July 1, August 12 and October 2, 2026, and Oppenheimer and Guggenheim also kept their ratings on July 1, 2026. The median 12-month target is $53.00, with a range from $40.00 to $83.00. Insiders made 17 sales worth $3.5M over the last 18 months, and 3 open-market purchases worth $428K. Insider sales are often planned in advance or made to cover tax on vesting shares, so the purchases carry more weight as a signal.

The base case is that PRGS holds above its moving averages while the market judges whether earnings strength can turn into revenue growth. The stock sits above its 20-day EMA, 50-day SMA and 200-day SMA, and the 50-day average is 13.50% above the 200-day average, which keeps the trend intact as long as those averages keep rising. Upside depends on revenue returning to growth; the median analyst target of $53.00 and the high of $83.00 assume that happens. A break below the 20-day EMA would be the first sign that the recent rally is losing support, and a sustained fall toward the 50-day SMA would weaken the case. Because the stock fell sharply after the last two reports that came with a beat, the next report is a key test of whether the market rewards beats again. Simulations from past volatility are not forecasts, and the typical daily move of 2.04% shows how wide the range of outcomes can be.

Support below the price: the 20-day EMA at $43.67 is the nearest level, and a fall would meet it first. Next is the 50-day SMA at $41.78, which has been rising and tracks the medium-term trend. Below that is the 200-day SMA at $36.81, the long-term trend line, followed by the 52-week low of $23.82. Resistance above the price: the 52-week high of $47.25 is the only level overhead, and a rise would meet it first. A move through it would set a new 52-week high.